Congratulations to the Department of Internal Medicine! The Journal of Investigative Medicine High Impact Case Reports recently published "Malignant Peritoneal Mesothelioma: A Rase Cause of Ascites," authored by SIU Medicine faculty and residents Ibrahim AM, Al-Akchar M, Obaidi Z, and Al-Johany H. https://www.ncbi.nlm.nih.gov/pubmed/30349836 J Investig Med High Impact Case Rep. 2018 Oct 16;6:2324709618807506. doi: 10.1177/2324709618807506. eCollection 2018 Jan-Dec. PMID: 30349836 Free PMC Article

INSTRUCTIONS FOR THE WRITTEN PROPOSAL The written document will be written in the format of a grant proposal. The proposal should not exceed 17 single-spaced pages. Recommended format: o Cover page (1 page, not counted in page limit) o Specific Aims Page (1 page) o Literature review with Significance and Innovation (up to 10 pages) o Research plan (6 pages) o References (no limit, not counted in the page limits) Use Times New Roman or Arial font, no smaller than 11 point Margins must be at least 0.5 in. on all sides. For guidance, follow the research plan instructions for a pre-doctoral Ruth L

Rural Health Summit Releases Report on Rural Health in Illinois Identifies great challenges and a path forward Springfield, Ill. - Rural Illinois residents face significant challenges and health disparities compared to residents in the state’s metropolitan areas, according to a new report released by the organizers of the 2018 Illinois Rural Health Summit. The report, titled “ THE STATE OF RURAL HEALTH IN ILLINOIS: Great Challenges and a Path Forward ” compiles information shared by rural health stakeholders across government, healthcare, public health, philanthropy and academia. The report

2018 CHEST Annual Meeting, San Antonio, Texas. October 6-10, 2018. Please visit http://chestmeeting.chestnet.org/ for more information regarding the 2019 CHEST Annual Meeting in New Orleans, LA. Congratulations to our very own, Mirza Ali, MD and Abdisamad Ibrahim, MD, both PGY2's, and Abhishek Kulkarni, MD on your poster acceptance at the 2018 Annual CHEST Meeting in San Antonio, Texas. Dr. Ali and Dr. Ibrahim traveled to Texas on October 6-10, 2018 to present their poster "Unusual Case of NSTFMI Associated with Myocardial Bridge". Dr. Mirza Ali along with his mentor Dr. Abhishek Kulkarni

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

Eric Adjei Boakye, PhD, MA Assistant Professor Department of Population Science and Policy Contact 217-545-8511 eadjeiboakye49@siumed.edu Primary Responsibilities My primary responsibilities include pursuing individual and collaborative research in human papillomavirus (HPV), HPV-associated cancers, and in cancer disparities; as well as providing education and mentoring to medical students, residents and fellows. About I received both my bachelors (Computer Information Systems) and masters (Healthcare Management) in Minnesota. Whiles working on my masters, I worked for Mayo Clinic in Rochester

REDCap is a HIPAA compliant, secure web application for building and managing online surveys and databases. REDCap can be used to collect data for many purposes, including online or offline data capture for research studies, quality improvement projects, and general administrative operations. SIU School of Medicine hosts REDCap on SIU-SOM servers. All SIU-SOM employees may request REDCap projects. REDCap is managed by the Statistics and Informatics Core within the Center for Clinical Research. The Statistics Core will set-up REDCap projects, create and maintain data entry and survey